Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.

about

Protein lipoxidation: Detection strategies and challenges

P2860

Q26824737-6D770C62-9EBC-4439-9AAC-6291E564E2CB

P2860

Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.

Item

http://www.wikidata.org/entity/Q38077549

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic potential of targe ...... e treatment of ocular disease.

@en

type

Item

label

Therapeutic potential of targe ...... e treatment of ocular disease.

@en

prefLabel

Therapeutic potential of targe ...... e treatment of ocular disease.

@en

P1476

Therapeutic potential of targe ...... he treatment of ocular disease

@en

P2093

J Graham McGeown

http://www.w3.org/2001/XMLSchema#string

Rosemary E McDowell

http://www.w3.org/2001/XMLSchema#string

P2860

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Complement factor H polymorphism in age-related macular degeneration

Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Complement factor H variant increases the risk of age-related macular degeneration

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Nrf2-Keap1 defines a physiologically important stress response mechanism

Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress

P304

189-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.12.202

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tim M. Curtis

Alan W Stitt

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235381542

http://www.w3.org/2001/XMLSchema#string

P698

23360143

http://www.w3.org/2001/XMLSchema#string

Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.

about

P2860

P2860

Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698